Men and women exhibit differences in the development and progression of Alzheimer's
disease (AD). The factors underlying the sex differences in AD are not well understood. This …

After advanced age, female sex is the major risk factor for late-onset Alzheimer's disease
(AD), the most common cause of dementia affecting over 24 million people worldwide. The …

Alzheimer's dementia is significantly more common in women than in men. However, few
pathological studies have addressed sex difference in Alzheimer's disease (AD) and other …

Importance The strongest genetic risk factor for Alzheimer disease (AD), the apolipoprotein
E (APOE) gene, has a stronger association among women compared with men. Yet limited …

Women are disproportionately affected by Alzheimer's disease (AD) in terms of both disease
prevalence and severity. Previous autopsy work has suggested that, in the presence of AD …

During the menopausal transition, which begins four to six years before cessation of
menses, middle-aged women experience a progressive change in ovarian activity and a …

Since Dr. Brizendine wrote The Female Brain ten years ago, the response has been
overwhelming. This New York Times bestseller has been translated into more than thirty …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that accounts for
more than half of all dementia cases in the elderly. Interestingly, the clinical manifestations of …

Introduction Despite a large preclinical literature demonstrating neuroprotective effects of
estrogen, use of menopausal hormone therapy (HT) for Alzheimer's disease (AD) risk …

Estrogen is an important hormone signal that regulates multiple tissues and functions in the
body. This review focuses on the neurotrophic and neuroprotective actions of estrogen in the …